ARVs
Atripla (efavirenz + tenofovir DF + FTC)
2 February 2020. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes
Generic versions of Atripla (pictured) will look different. Generic versions include Atenef, Atreslawin, Atroiza, Citenvir, Heftenam, Odimune, Rizene, Teevir, Trenvir, Tribuss, Triolar, Trivenz, Truno, Trustiva, Viraday and Vonavir. The WHO refer to this combination as AF2B.
Biktarvy: bictegravir/emtricitabine/TAF
30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes
Biktarvy is a pink/grey film-coated tablet (15 mm x 8 mm) with “GSI” on one side and “9883” on the other.
cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)
1 August 2024. Related: ARVs, Integrase inhibitors, NNRTIs
(not to scale)
Cabotegravir-LA and rilpivirine-LA are long acting injections given by intramuscular injections every two months.
Full details about cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)
Descovy (TAF + emtricitabine)
12 May 2018. Related: ARVs, Nukes
10/200 mg (white) and 25/200 mg (blue)
dolutegravir
30 August 2024. Related: ARVs, Integrase inhibitors
Dolutegravir 50 mg is a 9 mm diameter round yellow tablet.
doravirine (Pifeltro)
18 November 2018. Related: ARVs, NNRTIs
Doravirine is a white tablet embossed with “700” on one side. (Source: aidsinfo.nih)
doravirine/TDF/3TC FDC (Delstrigo)
18 September 2019. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes
Delstrigo is a light yellow tablet embossed with “776” on one side. (Source: aidsinfo.nih)
Dovato (dolutegravir + lamivudine)
30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes
Dovato is a white tablet embossed with “SV137”. (Source: aidsinfo.nih)
elvitegravir
1 May 2018. Related: ARVs, Integrase inhibitors
Single drug formulations of elvitegravir are no longer used. Instead, elvitegravir is included with other drugs in fixed dose combinations.
Eviplera (rilpivirine + tenofovir + FTC)
3 May 2013. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes
Generic ARVs
30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs, Nukes, PIs
A generic drug is one that is manufactured by a different pharmaceutical company to the company that invented the medicine.
Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)
12 April 2016. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes, PK booster
Full details about Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)
Ibalizumab
22 March 2023. Related: ARVs, Entry inhibitors, monoclonal antibody (mAb)
Ibalizumab is a 200 mg concentrate that is then made up as an infusion.
Juluca (dolutegravir + rilpivirine)
12 May 2018. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs
nelfinavir
4 January 2022. Related: ARVs, PIs
No longer recommended in the UK. No longer manufactured.
nevirapine
1 April 2013. Related: ARVs, NNRTIs
Nevirapine 200 mg
Nevirapine-PR (prolonged release) 400 mg
Odefsey (rilpivirine + TAF + emtricitabine)
4 January 2022. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes
Full details about Odefsey (rilpivirine + TAF + emtricitabine)
Prezcobix (darunavir + cobicistat) US name
12 April 2016. Related: ARVs, PIs, PK booster
Full details about Prezcobix (darunavir + cobicistat) US name
raltegravir
3 January 2022. Related: ARVs, Integrase inhibitors
Once-daily (600mg) Twice-daily (400 mg)
ritonavir
1 April 2013. Related: ARVs, PIs, PK booster
New Meltrex tablet (non-refrigerated)
Old (original) capsule (requires refrigeration)
Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)
4 January 2022. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes
Full details about Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)
Symtuza (darunavir + cobicistat + emtricitabine + TAF)
12 May 2018. Related: ARVs, Fixed dose combinations, Nukes, PIs
Full details about Symtuza (darunavir + cobicistat + emtricitabine + TAF)
tenofovir alafenamide (TAF)
12 February 2018. Related: ARVs, Nukes
No picture: TAF will only be available in coformulations with other HIV drugs.
TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)
1 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs
Picture not included as there are many different versions.
Full details about TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)
Triumeq (dolutegravir + abacavir + 3TC)
30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes
